IDRA | Idera Pharmaceuticals, Inc. Company profile
Company profileIdera Pharmaceuticals is a clinical-stage biopharmaceutical company developing tilsotolimod, a Toll-like receptor (TLR) 9 agonist for the treatment of certain cancers. Tilsotolimod is focused on priming the immune system to play a more powerful role in fighting cancer, ultimately increasing the number of people who can benefit from immunotherapy. Address505 Eagleview Boulevard | NotesJump to (Finance sites)         ResearchInvestor pageir.iderapharma.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite. Homepage: iderapharma.comTheir Official Profiles  Other stocks            Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended Books Buy on Amazon Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up? |